发明名称 DIAGNOSIS OF SEPSIS OR SIRS USING BIOMARKER PROFILES
摘要 The early prediction or diagnosis of sepsis advantageously allows for clinical intervention before the disease rapidly progresses beyond initial stages to the more severe stages, such as severe sepsis or septic shock, which are associated with high mortality. Early prediction or diagnosis is accomplished by comparing an individual's profile of biomarker expression to profiles obtained from one or more control, or reference, populations, which may include a population that develops sepsis. Recognition of features in the individual's biomarker profile that are characteristic of the onset of sepsis allows a clinician to diagnose the onset of sepsis from a bodily fluid isolated from the individual at a single point in time. The necessity of monitoring the patient over a period of time is, therefore, avoided, advantageously allowing clinical intervention before the onset of serious symptoms of sepsis. Further, because the biomarker expression is assayed for its profile, identification of the particular biomarkers is unnecessary. The comparison of an individual's biomarker profile to biomarker profiles of appropriate reference populations likewise can be used to diagnose SIRS in the individual.
申请公布号 AU2003291482(A1) 申请公布日期 2004.06.03
申请号 AU20030291482 申请日期 2003.11.12
申请人 BECTON, DICKINSON AND COMPANY 发明人 PAUL GOLDENBAUM;SONG SHI;DONALD COPERTINO;JAMES GARRETT;GREGORY TICE;RICHARD IVEY;THOMAS GENTLE;RICHARD MOORE;MICHAEL TOWNS;NICHOLAS BACHUR;ROBERT ROSENSTEIN;JAMES NADEAU
分类号 C12Q1/68;G01N33/68 主分类号 C12Q1/68
代理机构 代理人
主权项
地址